Disease Forecasting Platform Market Report 2026

The disease forecasting platform market size has grown exponentially in recent years. It will grow from $2.76 billion in 2025 to $3.41 billion in 2026 at a compound annual growth rate (CAGR) of 23.8%. The growth in the historic period can be attributed to increasing incidence of infectious disease outbreaks, expansion of epidemiological research capabilities, availability of large health datasets, adoption of cloud-based analytics platforms, growth of public health surveillance programs.

The disease forecasting platform market size is expected to see exponential growth in the next few years. It will grow to $7.96 billion in 2030 at a compound annual growth rate (CAGR) of 23.6%. The growth in the forecast period can be attributed to increasing investments in predictive healthcare analytics, rising demand for early outbreak detection tools, expansion of AI-driven public health platforms, growing integration of IoT-based health monitoring, increasing focus on proactive disease prevention. Major trends in the forecast period include increasing deployment of AI-based disease prediction models, rising integration of real-time health data streams, growing use of environmental and demographic analytics, expansion of early warning and alert systems, enhanced focus on predictive public health planning.

The rising prevalence of non-communicable diseases is expected to drive the growth of the disease forecasting platform market in the coming years. Non-communicable diseases are medical conditions that are not transmitted between people and usually develop due to genetic, lifestyle, or environmental factors, such as heart disease, diabetes, and cancer. Their increasing prevalence is linked to unhealthy lifestyles, including poor diet, smoking, and physical inactivity. Disease forecasting platforms assist in managing non-communicable diseases by utilizing big data analytics, machine learning, and real-time health monitoring to predict disease trends, identify high-risk populations, enable early interventions, and guide personalized prevention strategies. This ultimately improves public health outcomes and reduces the burden of chronic conditions. For example, in July 2025, the Kenya National Bureau of Statistics reported in its Kenya Vital Statistics Report that non-communicable diseases accounted for 61.7% of the total disease burden in 2024, up from 52.4% in 2023. Hence, the rising prevalence of non-communicable diseases is driving the growth of the disease forecasting platform market.

Key players in the disease forecasting platform market are focusing on innovative technologies, such as artificial intelligence-driven predictive analytics, to enable real-time disease surveillance and proactive public health responses. AI-driven predictive analytics involves the use of artificial intelligence, including machine learning algorithms and statistical modeling, to forecast disease trends, detect anomalies early, and provide actionable insights for timely intervention and resource allocation. For instance, in July 2025, Seegene Inc., a South Korea-based biotechnology company, launched the STAgora platform. This platform integrates PCR-derived diagnostic data with over 40 advanced statistical and AI tools to provide real-time, global visualization of infectious disease trends. It enables early detection of abnormal pathogen patterns, supports predictive outbreak modeling, and enhances situational awareness at municipal to global levels. It is designed to function as a real-time infectious disease intelligence system, supporting rapid response and proactive public health measures.

In March 2024, Healthy Together, a US-based health technology company specializing in software-as-a-service (SaaS) solutions, acquired Kinsa Health for an undisclosed amount. Through this acquisition, Healthy Together aims to incorporate Kinsa Health’s AI-powered illness forecasting technology into its SaaS solutions to strengthen real-time disease surveillance, expand into new markets, and provide early outbreak detection and predictive insights for public and private healthcare stakeholders. Kinsa Health Inc. is a US-based company offering AI-driven illness forecasting tools that use smart thermometers, mobile applications, and predictive analytics to deliver real-time early warnings and community-level trends for infectious illnesses.

Major companies operating in the disease forecasting platform market are International Business Machines Corporation, Oracle Corporation, Metabiota Inc., SAS Institute Inc., Tempus AI Inc., HealthVerity Inc., Airfinity Ltd., Quantori LLC, ProMED-mail Inc., EcoHealth Alliance Inc., BlueDot Inc., Hyfe Inc., Biobot Analytics Inc., Cayaba Care Inc., EPIWATCH Pty Ltd, GIDEON Informatics Inc., Kinsa Inc., Epistemix, Epidemico Inc., EpiDetect AI Inc.

North America was the largest region in the disease forecasting platform market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the disease forecasting platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the disease forecasting platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the disease forecasting platform market by increasing costs of imported servers, sensors, edge computing devices, networking equipment, and advanced analytics hardware used in real-time data processing. Public health agencies and research institutions in North America and Europe are most affected due to reliance on imported digital infrastructure, while Asia-Pacific faces cost pressures on hardware sourcing and platform scaling. These tariffs are increasing project implementation costs and slowing infrastructure expansion. However, they are also encouraging cloud-native platform adoption, regional data center investments, and localized analytics development that strengthen long-term forecasting capabilities.

The disease forecasting platform market research report is one of a series of new reports that provides disease forecasting platform market statistics, including disease forecasting platform industry global market size, regional shares, competitors with a disease forecasting platform market share, detailed disease forecasting platform market segments, market trends and opportunities, and any further data you may need to thrive in the disease forecasting platform industry. This disease forecasting platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A disease forecasting platform is a digital system that leverages data analytics, artificial intelligence, and predictive modeling to anticipate the spread, severity, and impact of diseases. It combines real-time health, environmental, and demographic data to generate early warnings, supporting timely interventions, resource planning, and the reduction of outbreak risks.

The key components of a disease forecasting platform include software, hardware, and services. Software encompasses the programs, applications, and algorithms used to process, analyze, and visualize health data, enabling predictive modeling, simulation, and reporting of disease trends. Deployment modes include cloud-based and on-premises solutions. Applications cover infectious disease surveillance, chronic disease management, epidemiology, public health, and more. These platforms are utilized by various end-users, including hospitals and clinics, government and public health agencies, research institutes, pharmaceutical companies, and others.

The disease forecasting platform market consists of revenues earned by entities by providing services such as data collection, data integration, predictive modeling, real-time monitoring, analytics and visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. The disease forecasting platform market also includes sales of sensors, servers, data storage systems, networking equipment, edge devices, and monitoring devices. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.